VUF 5087
Latest Information Update: 22 Aug 2002
At a glance
- Originator Kowa; Nonindustrial source
- Class Antiasthmatics
- Mechanism of Action Leukotriene D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 16 Jun 1998 New profile
- 16 Jun 1998 Preclinical development for Asthma (Unknown route)